In a bid to extend its footprint in the multibillion-dollar endoscopy equipment market, Boston Scientific Corporation BSX has commercially launched its FDA-cleared Axios stent and electrocautery ...
The US Food and Drug Administration (FDA) has allowed marketing of the Xlumena, Inc's Axios Stent and Delivery System for treating pseudocysts (fluid and tissue filled cavities) that form in the ...
Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...
MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- Xlumena, Inc. announces that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage. The device ...
MOUNTAIN VIEW, Calif., May 15, 2012 /PRNewswire/ -- Xlumena, Inc. announces the publication of a scientific paper describing the first human study of the AXIOS™ Stent and Delivery System. The article, ...
Boston Scientific has issued a recall letter to users of the Axios stent after FDA linked the device to three deaths and 167 serious injuries. The deaths were linked to use cases of the stent that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results